Answers are grounded in this paper and cite their sources.
Objective: This study evaluated the effectiveness of the Cancer Pain Monitoring System (CAPAMOS), a tele-nursing system for cancer pain relief. Methods: A pilot randomized controlled trial was conducted from October 2019 to February 2023 among outpatients at Tohoku University Hospital. Participants were randomly assigned in a 1:1 ratio to either the intervention or the control group. Eligible patients reported an average pain score of ≥ 3 on the numerical rating scale over 24 hours. Pain, self-management, and quality of life (QoL) were assessed through questionnaires at enrolment (T0), and at two (T1) and four weeks (T2). Conclusions: This study found no significant difference between the CAPAMOS and control groups after four weeks. However, the CAPAMOS group showed improvements in cancer pain and its impact on daily life. This suggests that CAPAMOS tele-nursing intervention may require more than four weeks for effective pain relief. Trial registration: The study was registered with the University Hospital Medical Information Network (UMIN Clinical Trial Registry ID: 000038334).
No takes yet. Share an insight, caveat, or question.
Yoshida et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: